Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

4.23
-0.2150-4.84%
Volume:345.83K
Turnover:1.49M
Market Cap:391.54M
PE:-9.13
High:4.55
Open:4.44
Low:4.17
Close:4.44
52wk High:13.99
52wk Low:2.86
Shares:92.67M
Float Shares:83.05M
Volume Ratio:0.76
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4626
EPS(LYR):-0.5438
ROE:-33.63%
ROA:-21.56%
PB:3.09
PE(LYR):-7.77

Loading ...

Anavex Life Sciences: Navigating Legal Risks and Regulatory Challenges in a High-Stakes Industry

TIPRANKS
·
Nov 27, 2025

Anavex Life Sciences Earnings Call: Mixed Sentiments and Future Prospects

TIPRANKS
·
Nov 27, 2025

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 27, 2025

Anavex Life Sciences Reports Q4 2025 Financials and Updates

TIPRANKS
·
Nov 26, 2025

Anavex Life Sciences reports no revenue and higher general and administrative expenses for fiscal 2025

Reuters
·
Nov 26, 2025

BRIEF-Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results

Reuters
·
Nov 25, 2025

Anavex Life Sciences Q4 EPS $(0.11) Beats $(0.15) Estimate, With Current Cash Balance Of Over $120M, The Company Anticipates At Its Current Cash Utilization Rate, An Approximate Cash Runway Of More Than 3 Years

Benzinga
·
Nov 25, 2025

Anavex Life Sciences Corp: Anticipates at Its Current Cash Utilization Rate, Approximate Cash Runway of More Than 3 Years

THOMSON REUTERS
·
Nov 25, 2025

Anavex Life Sciences Corp Qtrly EPS $-0.11

THOMSON REUTERS
·
Nov 25, 2025

Press Release: Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

Dow Jones
·
Nov 25, 2025

Top News Today/Canada: Barrick Makes a Deal With Mali

Dow Jones
·
Nov 25, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 24, 2025

Anavex Life Sciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 19, 2025

Anavex price target lowered to $20 from $42 at H.C. Wainwright

TIPRANKS
·
Nov 19, 2025

Anavex Life Sciences Corp. : H.c. Wainwright Cuts Target Price to $20 From $42

THOMSON REUTERS
·
Nov 19, 2025

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

GlobeNewswire
·
Nov 18, 2025

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 15, 2025

Anavex Life Sciences Down Over 35%, on Pace for Largest Percent Decrease Since November 2020 -- Data Talk

Dow Jones
·
Nov 15, 2025

Top Midday Decliners

MT Newswires Live
·
Nov 15, 2025

Analysts Are Neutral on Top Healthcare Stocks: Anavex Life Sciences (AVXL), IO Biotech (IOBT)

TIPRANKS
·
Nov 15, 2025